Eline D'Joos

Eline has advised multinational companies and start-ups as well as research institutes in the pharmaceutical, biotech, and medical devices sectors on a variety of complex matters, including clinical trials, product approvals, regulatory incentives, market access, biosimilars, orphan drugs, pediatrics, and Belgian supplementary protection certificates. Digital transformation in the health sector is also one of Eline’s main focus areas.

Eline also has experience in drafting and negotiating high value IP licenses, R&D collaborations, and commercial agreements. In addition, she has assisted with mergers and acquisitions of life sciences companies as well as patent infringement proceedings and preliminary injunctions.